Chester County News and Community Website
BERWYN, PA — Panavance Therapeutics Inc. has announced the publication of encouraging data on misetionamide in the peer-reviewed journal, Cancer Medicine. The study conducted by Kim et al. at MD …
Panavance Therapeutics Reports Positive Data on Misetionamide in Ovarian Cancer Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced that it will present significant interim findings from its randomized Phase 1b FURTHER study on firmonertinib monotherapy. This presentation …
ArriVent BioPharma to Present Groundbreaking Data at 2024 World Conference on Lung Cancer Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued an update on the ongoing multistate outbreak of Listeria monocytogenes infections. The latest data highlights an increase …
CDC Updates on Multistate Listeria Outbreak Linked to Boar’s Head Deli Meats Read More
WASHINGTON, D.C. — Recent data from the Centers for Disease Control and Prevention (CDC) reveal both improvements and troubling trends in the mental health and safety of American teens. The …
CDC Reports Mixed Trends in Teen Mental Health and Safety Read More
HARRISBURG, PA — The Pennsylvania Department of Health (DOH) announced it will distribute free potassium iodide (KI) tablets on August 22 to residents and workers within 10 miles of the …
Pennsylvania Department of Health to Distribute Free Potassium Iodide Tablets Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) announced new preclinical data showing the positive combined effects of its lead compound, buntanetap, with the GLP-1 agonist dulaglutide (Trulicity®) in an …
Annovis Bio Shows Synergistic Effect of Buntanetap and Dulaglutide in Alzheimer’s Treatment Read More
NORTH EAST, MD — Cecil College’s Licensed Practical Nurse (LPN) program honored its Class of 2024 with a Pinning Ceremony on July 24. Held in the Technology Center on the …
Cecil College Celebrates LPN Class of 2024 with Pinning Ceremony Read More
HARRISBURG, PA — In a proactive step to address the growing xylazine crisis, the Pennsylvania Department of Health (DOH), led by Secretary Dr. Debra Bogen, announced on Friday the distribution …
Pennsylvania Distributes 50,000 Xylazine Wound Care Kits to Combat Drug Epidemic Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has approved the Shield test, developed by Guardant Health, Inc., for colorectal cancer (CRC) screening. This test uses blood collected in …
FDA Approves Guardant Health Blood Test for Colorectal Cancer Screening Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has approved an expansion for the use of Palforzia, a treatment designed to mitigate allergic reactions in children with peanut allergies. …
FDA Approves Expanded Use of Palforzia for Young Children with Peanut Allergies Read More